N/A
N=337
Telemedicine in High-Risk Cardiovascular Patients Post-ACS
Cardiovascular Diseases · Acute Coronary Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT05015634 ↗Enrolled (actual)
337
Serious AEs
14.5%
Results posted
Feb 2026
Primary outcome: Primary: Number of Participants With Hospital Readmission at 6 Months — 13; 48 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Active Arm (Other); Control Arm (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Imperial College London
- Primary completion
- Feb 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Hospital Readmission at 6 Months |
13; 48 | — |
| PRIMARY Emergency Department Visits at 6 Months |
39; 62 | — |
| SECONDARY Length of Stay |
1.2; 1.8 | — |
| SECONDARY All-cause Mortality |
1.2; 1.2 | — |
| SECONDARY Number of Participants With Major Adverse Cardiac Events (MACE) at 9 Months |
17; 21 | — |
| SECONDARY Medical Intervention |
4; 15 | — |
| SECONDARY 9 Months Readmission Rates |
20; 50 | — |
| SECONDARY Patient-Reported Quality of Life - 3 Months |
67.5; 68.9; 57.5; 52.5; 63.7; 60.0 | — |
| SECONDARY Patient-Reported Quality of Life - 6 Months |
73.0; 70.6; 65.9; 63.0; 70.0; 71.0 | — |
| SECONDARY Patient-Reported Quality of Life - 9 Months |
75.5; 69.5; 71.2; 59.2; 79.0; 66.2 | — |
Summary
This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote, clinically necessary, diagnostic information, without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack.
Eligibility Criteria
Inclusion Criteria
- 1 ACS Patients diagnosed with elevated hs-cTnI I who have undergone coronary intervention for NSTEMI or STEMI or unstable angina.
- 2 In addition, the participant should have at least one additional cardiovascular risk factor:
- Current or ex-Tobacco Use
- Hypertension
- Diabetes
- Hypercholesterolaemia.
- Male aged > 50 years.
- 3 Access to a smartphone or smart device.
Exclusion Criteria
- 1 The inability to apply/use the telemonitoring equipmentt
- 2 Life expectancy of 9 months or less.
Data sourced from ClinicalTrials.gov (NCT05015634). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.